Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Insulin blockbusters targeted by biosimilar blitz

February 15, 2013 Research and Development, Sales and Marketing Biocon, Humalog, Mylan, insulin

Mylan and Biocon are the latest companies to announce major new plans to develop and market biosimilars. The firms are …
News

Janssen launches dementia prize

February 15, 2013 Sales and Marketing Hunt, Janssen, NHS, dementia

Janssen has joined forces with the NHS to launch a scheme to financially reward solutions which can help the lives …
News

Lancet sparks agency row

February 15, 2013 Medical Communications, Sales and Marketing ABPI, Lancet, Luther Pendragon, Marlboro, Phillip Morris

Communications agency Luther Pendragon has parted company with cigarette firm Philip Morris after attention was drawn to the agency’s other …
News

Nanobiotix appoints ex-Sanofi head Alain Herrera

February 14, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix

Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …
Appointment

BMS hires Ann Powell Judge from Shire

February 14, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Powell Judge, BMS, Shire

BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …
Appointment

Shire ADHD drug for UK

February 14, 2013 Sales and Marketing ADHD, Shire, Vyvanse, elvanse

Shire’s attention-deficit hyperactivity disorder (ADHD) drug Elvanse has been given the go-ahead for use in the UK. Elvanse (lisdexamfetamine dimesylate), …
News

Delivering value in cost-constrained healthcare environments

February 14, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, MSI, NHS, VBP, austerity, value

As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …
Feature

BMS in $438m OTC deal

February 14, 2013 Sales and Marketing BMS, Reckitt Benckiser

Bristol-Myers Squibb has signed over the rights to sell, distribute and market half a dozen of its medicines, mainly sold …
News

Universal WorldEvents creates dedicated training role

February 14, 2013 Medical Communications, Research and Development, Sales and Marketing Universal WorldEvents

Event management firm Universal WorldEvents has announced the promotion of Sarah Longland to the new role of senior account manager …
Appointment

NICE rejects Jakavi

February 13, 2013 Sales and Marketing Jakavi, NICE

NICE has today issued draft guidance saying it does not recommend Novartis’ Jakavi for patients with myelofibrosis, a rare blood …
News

Ironwood announces new president of R&D

February 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Ironwood

Ironwood Pharmaceuticals has announced the promotion of Mark Currie, to senior vice president, chief scientific officer, and president of research …
Appointment

Sanofi ups stake in Regeneron

February 13, 2013 Sales and Marketing AMD, Regeneron, Sanofi, Zaltrap

Sanofi is increasing its stake in Regeneron Pharmaceuticals by buying shares on the open market and from existing shareholders. The …
News

Shire pays Impax $48 million

February 12, 2013 Sales and Marketing ADHD, Adderall, Impax, Shire

Shire has paid $48 million to settle a long-running legal spat with Impax Laboratories over Shire’s supply of an authorised …
News

Mylan appoints two heads to Board of directors

February 12, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Mylan

Mylan has announced the appointment of Melina Higgins, a former partner at Goldman Sachs, and Rajiv Malik, currently Mylan’s president, …
Appointment

FDA rejects Novo diabetes drugs

February 12, 2013 Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba

The FDA has knocked back two of Novo Nordisk’s diabetes drugs – just weeks after they were approved for use …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026